Memphis, TN, United States of America

Jamie Jarusiewicz

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: St. Jude Children's Research Hospital. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jamie Jarusiewicz: Innovator in Cellular Treatment

Introduction

Jamie Jarusiewicz is an accomplished inventor based in Memphis, TN (US). She has made significant contributions to the field of medical research, particularly in the treatment of uncontrolled cellular proliferation. Her work is vital in advancing therapeutic methods that can improve patient outcomes.

Latest Patents

Jamie holds a patent titled "Molecules and Methods Related to Treatment of Uncontrolled Cellular Proliferation." This patent represents her innovative approach to addressing critical health challenges associated with cellular growth disorders. She has 1 patent to her name, showcasing her dedication to research and development in this important area.

Career Highlights

Jamie is currently employed at St. Jude Children's Research Hospital, where she collaborates with leading experts in pediatric medicine. Her role at this prestigious institution allows her to contribute to groundbreaking research that has the potential to save lives.

Collaborations

Throughout her career, Jamie has worked alongside talented colleagues, including Jaeki Min and Marcelo Actis. These collaborations have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

In summary, Jamie Jarusiewicz is a notable inventor whose work in the treatment of uncontrolled cellular proliferation is making a difference in medical research. Her contributions at St. Jude Children's Research Hospital highlight her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…